Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:37 PM
Ignite Modification Date:
2025-12-24 @ 11:37 PM
NCT ID:
NCT01014156
Eligibility Criteria:
Inclusion Criteria:
* acute (symptoms \<24 hrs) with right ventricular dilatation (\>30 mm end diastolic, systolic PAP \> 50 mmHg,
* absence of right ventricular wall hypertrophy)
Exclusion Criteria:
* age below 18 years or above 70 years
* body mass index \>35 kg/m2
* duration of symptoms \>24 hours (since onset or acute increase in symptoms)
* severe circulatory shock (systemic blood pressure systolic \<80 mmHg, or diastolic blood pressure \<45 mmHg) or respiratory failure, requiring mechanical ventilation.
* patients who, in the opinion of the supervising physician, require thrombolytic therapy.
* severe pre-existent cardiopulmonary disease (heart failure, obstructive pulmonary disease, emphysema)
* atrial fibrillation
* refusal or inability to give informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01014156
Study Brief:
Protocol Section:
NCT01014156